首页> 外文OA文献 >A Randomized Controlled Trial to Examine the Effect of 2-Year Vitamin B12 and Folic Acid Supplementation on Physical Performance, Strength, and Falling: Additional Findings from the B-PROOF Study
【2h】

A Randomized Controlled Trial to Examine the Effect of 2-Year Vitamin B12 and Folic Acid Supplementation on Physical Performance, Strength, and Falling: Additional Findings from the B-PROOF Study

机译:一项随机对照试验,研究2年补充维生素B12和叶酸对体能,力量和摔倒的影响:B-Proof研究的其他发现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Elevated homocysteine concentrations are associated with a decline in physical function in elderly persons. Homocysteine-lowering therapy may slow down this decline. This study aimed to examine the effect of a 2-year intervention of vitamin B12 and folic acid supplementation on physical performance, handgrip strength, and risk of falling in elderly subjects in a double-blind, randomized placebo-controlled trial. Participants aged ≥65 years with elevated plasma homocysteine concentrations [12-50 µmol/L (n = 2919)] were randomly assigned to daily supplementation of 500 µg vitamin B12, 400 µg folic acid, and 600 IU vitamin D3, or to placebo with 600 IU vitamin D3. Physical performance (range 0-12) and handgrip strength (kg) were measured at baseline and after 2 years. Falls were reported prospectively on a research calendar. Intention-to-treat (primary) and per-protocol (secondary) analyses were performed. Physical performance level and handgrip strength significantly decreased during the follow-up period, but this decline did not differ between groups. Moreover, time to first fall was not significantly different (HR: 1.0, 95% CI 0.9-1.2). Secondary analyses on a per-protocol base identified an interaction effect with age on physical performance. In addition, the treatment was associated with higher follow-up scores on the walking test (cumulative OR: 1.3, 95% CI 1.1-1.5). Two-year supplementation of vitamin B12 and folic acid was neither effective in reducing the age-related decline in physical performance and handgrip strength, nor in the prevention of falling in elderly persons. Despite the overall null-effect, the results provide indications for a positive effect of the intervention on gait, as well as on physical performance among compliant persons >80 years. These effects should be further tested in future studies
机译:高半胱氨酸浓度升高与老年人身体机能下降有关。降低同型半胱氨酸疗法可减缓这种下降。这项研究旨在通过一项双盲,随机安慰剂对照试验,研究对维生素B12和叶酸补充剂进行为期2年的干预对老年受试者的身体机能,握力和跌倒风险的影响。年龄≥65岁且血浆同型半胱氨酸浓度升高[12-50 µmol / L(n = 2919)]的参与者被随机分配为每天补充500 µg维生素B12、400 µg叶酸和600 IU维生素D3,或安慰剂600 IU维生素D3。在基线和2年后测量身体表现(范围0-12)和握力(kg)。在研究日历上预先报告了跌倒情况。进行了意向性治疗(主要)和按方案(次要)分析。在随访期间,身体表现水平和握力明显下降,但两组之间的下降没有差异。此外,第一次跌倒的时间没有显着差异(HR:1.0,95%CI 0.9-1.2)。在基于协议的基础上进行的二级分析确定了年龄对身体表现的交互作用。此外,该治疗与步行测试中较高的随访评分相关(累计OR:1.3,95%CI 1.1-1.5)。两年补充维生素B12和叶酸既不能有效减少与年龄有关的身体机能和握力下降,也不能有效防止老年人跌倒。尽管总体上具有零影响,但结果表明干预对步态以及80岁以上顺应性人群的身体表现有积极影响。这些影响应在以后的研究中进一步测试

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号